Subscribe

What are you looking for?

Main Menu

明報新聞網

康希諾生物：國家藥監局批准嬰幼兒用DTcP新藥上市申請

Future Wealths
Future Wealths
12 4 月, 2026
One Min Read
11 Views
0 Comments
康希諾生物（6185）發通告指，中國國家藥品監督管理局已批准，公司所研發的嬰幼兒用吸附無細胞百（三組分）白破聯合疫苗（DTcP ）（ 2歲以下）（簡稱嬰幼兒用DTcP），其商品名稱為「盼康欣®」的新藥上市申請（NDA）。

原文: https://finance.mingpao.com/fin/instantf/20260412/1775992334473/%E5%BA%B7%E5%B8%8C%E8%AB%BE%E7%94%9F%E7%89%A9-%E5%9C%8B%E5%AE%B6%E8%97%A5%E7%9B%A3%E5%B1%80%E6%89%B9%E5%87%86%E5%AC%B0%E5%B9%BC%E5%85%92%E7%94%A8dtcp%E6%96%B0%E8%97%A5%E4%B8%8A%E5%B8%82%E7%94%B3%E8%AB%8B%22%20target=%22blank

Last Update: 12 4 月, 2026

Please share this article if you like it!

Link Copied!
Future Wealths
Written By

Future Wealths

Other Articles

Related Posts

Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.

Accept